Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Salmonella flagellin is the primary structural protein of the bacterial flagellum, typically encoded by the fliC or fljB genes in Salmonella species. It functions as a potent pathogen-associated molecular pattern (PAMP) that is specifically recognized by the host's Toll-like receptor 5 (TLR5), triggering the activation of the NF-kappaB signaling pathway and the subsequent production of pro-inflammatory cytokines and anti-apoptotic proteins (UniProt Consortium, 2023; Leigh et al., 2014). In therapeutic development, flagellin-derived molecules such as Entolimod (CBLB502) are utilized as TLR5 agonists to protect healthy tissues from radiation-induced damage and to stimulate anti-tumor immune responses (Burdelya et al., 2008). Additionally, flagellin is widely used as a vaccine adjuvant due to its ability to enhance the immunogenicity of co-administered antigens by activating dendritic cells and promoting a robust adaptive immune response (Huleatt et al., 2008). Despite its therapeutic potential, challenges include the risk of systemic inflammatory side effects, such as cytokine release syndrome, and the potential for the development of neutralizing anti-flagellin antibodies that may limit the efficacy of repeated administrations (Kandimalla et al., 2007).
Agonism of Toll-like receptor 5 (TLR5) leading to the activation of NF-kappaB and AP-1 signaling pathways, which induces the expression of protective cytokines and anti-apoptotic factors (Burdelya et al., 2008; Leigh et al., 2014).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella flagellin protein (FliC) (FliC).